Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book

被引：6
|
作者：
Santos, Raul D. [1 ,2 ]
Rocha, Viviane Z. [1 ]
机构：
[1] Univ Sao Paulo, Med Sch Hosp, Heart Inst InCor, Lipid Clin, Av Dr Eneas C Aguiar 44, BR-05403900 Sao Paulo, Brazil
[2] Hosp Israelita Albert Einstein, Acad Res Org, Sao Paulo, Brazil
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 02期
关键词：
EVOLOCUMAB;
D O I：
10.1093/eurheartj/ehac656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This editorial refers to 'Inclisiran and cardiovascular events: a patient-level analysis of phase III trials, by K.K. Ray et al., https://doi.org/10. 1093/eurheartj/ehac594.
引用
收藏
页码：139 / 141
页数：3
相关论文
共 50 条
  • [31] New class PCSK9 blockers stride into cholesterol market
    Cormac Sheridan
    Nature Biotechnology, 2015, 33 : 785 - 786
  • [32] Potential of PCSK9 as a new target for the management of LDL cholesterol
    Mombelli, Guiliana
    Castelnuovo, Samuela
    Pavanello, Chiara
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2015, 6 : 73 - 86
  • [33] New class PCSK9 blockers stride into cholesterol market
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2015, 33 (08) : 785 - 786
  • [34] Statins and PCSK9 inhibitors: A new lipid-lowering therapy
    Gallego-Colon, Enrique
    Daum, Aner
    Yosefy, Chaim
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878
  • [35] Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis
    Goto, Shinya
    Goto, Shinichi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024,
  • [36] PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option
    Pokrywka, Gregory S.
    POSTGRADUATE MEDICINE, 2018, 130 (03) : 287 - 298
  • [37] Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review
    Gianazza, Erica
    Macchi, Chiara
    Banfi, Cristina
    Ruscica, Massimiliano
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [38] PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Cainzos-Achirica, Miguel
    Martin, Seth S.
    Cornell, John E.
    Murow, Cynthia D.
    Guallar, Eliseo
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (01) : 64 - 65
  • [39] PCSK9 antibodies: A new class of lipid-lowering drugs
    Gouni-Berthold, Ioanna
    ATHEROSCLEROSIS SUPPLEMENTS, 2015, 18 : 21 - 27
  • [40] Cholesterol reduction by immunization with a PCSK9 mimic
    Zhang, Baoshan
    Chuang, Gwo-Yu
    Biju, Andrea
    Biner, Daniel
    Cheng, Jiaxuan
    Wang, Yiran
    Bao, Saran
    Chao, Cara W.
    Lei, Haotian
    Liu, Tracy
    Nazzari, Alexandra F.
    Yang, Yongping
    Zhou, Tongqing
    Chen, Steven J.
    Chen, Xuejun
    Kong, Wing-Pui
    Ou, Li
    Parchment, Danealle K.
    Sarfo, Edward K.
    Sima, Haomin
    Todd, John -Paul
    Wang, Shuishu
    Woodward, Ruth A.
    Cheng, Cheng
    Rawi, Reda
    Mascola, John R.
    Kwong, Peter D.
    CELL REPORTS, 2024, 43 (06):
12345